STAA.NASDAQStaar Surgical CO

Form 4: STAAR Surgical CFO Patrick F. Williams Reports Acquisition of Stock Options and Restricted Stock Units

Sentiment:

SEC Filing

📋All filings for Staar Surgical CO
🔒Login to Follow

Patrick F. Williams, CFO of STAAR Surgical, reports the acquisition of stock options and restricted stock units, according to a Form 4 filing with the SEC.

Summary

  • Patrick F. Williams, the Chief Financial Officer of STAAR Surgical Co., filed a Form 4 with the SEC on March 13, 2024.
  • The filing reports transactions that occurred on March 12, 2024.
  • Williams acquired 21,908 common stock options with an exercise price of $37.64.
  • These options vest in three tranches: 1/3 on March 12, 2025, and the remaining 2/3 vesting monthly over the following 24 months, with any remaining balance vesting on March 12, 2027.
  • Williams also acquired 24,460 restricted stock units (RSUs), each representing the right to receive one share of STAAR Surgical's common stock upon vesting.
  • These RSUs vest in three equal installments: 8,153 shares on March 12, 2025, 8,153 shares on March 12, 2026, and 8,154 shares on March 12, 2027.
  • Following these transactions, Williams directly owns 21,908 common stock options and 24,460 RSUs.

Sentiment

Score: 6

Explanation: The sentiment is neutral. It's a routine filing related to executive compensation. The acquisition of stock options and RSUs can be seen as a positive sign of confidence, but it's not a strong indicator.

Positives

  • The acquisition of stock options and RSUs by the CFO could be seen as a positive sign, indicating confidence in the company's future performance.

Future Outlook

The vesting schedules for the stock options and RSUs suggest a multi-year incentive plan for the CFO, aligning his interests with the long-term performance of the company.

Industry Context

Form 4 filings are a routine part of corporate governance, providing transparency into the transactions of company insiders. The acquisition of stock options and RSUs is a common form of executive compensation in the industry.

Stakeholder Impact

  • The acquisition of stock options and RSUs by the CFO aligns his interests with those of the shareholders, potentially incentivizing him to improve the company's performance.

Key Dates

DateDescription
03/12/2024Date of the reported transactions: acquisition of stock options and RSUs.
03/12/2025First vesting date for 1/3 (7,302 shares) of the stock options and 1/3 (8,153 shares) of the RSUs.
03/12/2026Second vesting date for 1/3 (8,153 shares) of the RSUs.
03/12/2027Final vesting date for the remaining stock options and 1/3 (8,154 shares) of the RSUs.
03/13/2024Date the Form 4 was filed with the SEC.

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.